Skip to main content
Independent science journalism
We do not sell or supply peptides
Peptide
Science
Daily
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Search
⌘K
Subscribe
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Theme
Subscribe to the newsletter
We do not sell or supply peptides.
Home
Trials
NCT00220350
Clinical Trials · NCT00220350
Lupron Sex Offender Therapy
Unknown
Phase 2/Phase 3
Gonadorelin
(Unclear)
Phase
Phase 2/Phase 3
Recruitment status
Unknown
Sponsor
Schober, Justine, M.D.
Enrollment
10
Start date
Oct 2001
Locations
1 site, United States
Primary endpoint
suppressed arousal
View Gonadorelin compound reference